Skip to content
★ Sign in to follow
LF

Longwood Fund, L.P.

Shareholder
Related company / holding
Verastem, Inc.Tempest Therapeutics, Inc.
Total declarations
14
Companies
2
▲ Purchases (2 ops.)
€3.6M
▼ Sales (0 ops.)
—

Latest filing published 16 Jan 2015 for Tempest Therapeutics, Inc..

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Longwood Fund, L.P.: trading record in brief

Longwood Fund, L.P. is a declared insider at 2 companies; the most frequent names are Tempest Therapeutics, Inc. and Verastem, Inc. The record holds 14 filings, for trades running from 1 February 2012 to 14 January 2015.

Every open-market trade on record is a purchase: 2 purchases worth €3.6M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant.

On 16 January 2015 came the latest disclosure, a transaction in Tempest Therapeutics, Inc. The most recent open-market purchase was published on 11 March 2014, 4,626 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Longwood Fund, L.P.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total

12 of 12 declarations